Purchase Order N0017315P3635
Award Date 7/10/15
Potential Completion Date 7/9/16
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Office of Naval Research awarded a $15,000 firm fixed-price purchase order to Illumina, Inc. on July 10, 2014, for the MiSeq Silver Contract, with completion targeted for July 9, 2015. The contract, which carries no set-aside designation, will be performed in San Diego, California. Illumina, a biotechnology company specializing in genetic sequencing and genomic analysis technologies, will deliver products or services supporting the Navy's research initiatives. The MiSeq platform is one of...
- This is a firm-fixed-price purchase order awarded by the Naval Medical Research Command to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The requirement is for a MiSeq i100 Plus System, a specialized DNA/RNA sequencing instrument. The $90,997.20 contract has an ultimate completion date of July 30, 2025. Illumina is a prime contractor providing a range of genomic sequencing platforms, reagents, consumables, and maintenance services to multiple federal civilian...
- The Office of Naval Research awarded a $5,675.74 firm fixed-price purchase order to Illumina, Inc. for laboratory supplies on May 5, 2017, with an ultimate completion date of August 3, 2017. The contract, issued without a set-aside designation, will be performed in San Diego, California, where Illumina maintains its headquarters. This purchase order represents a routine procurement of laboratory consumables and supplies from the biotechnology company, which specializes in genetic sequencing...
- The Office of Naval Research awarded a $16,302 firm fixed-price purchase order to Illumina, Inc. for reagent kits on September 26, 2013, with completion targeted for October 26, 2013. The contract, issued without a set-aside designation, will be performed in San Diego, California. Illumina is a biotechnology company specializing in genetic sequencing and genomic analysis technologies, providing DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software to federal...
- Illumina, Inc. was awarded a firm fixed-price purchase order valued at $15,470.75 for a DNA Sequencer MiSeq Comprehensive Plan annual service contract with quarterly payments. The contract, which was awarded on May 6, 2016, with an ultimate completion date of May 9, 2017, covers product care and maintenance services for the MiSeq sequencing instrument. The place of performance is located in San Diego, California, and the contract was funded by a civilian federal agency within the Midwest Area....
- The U.S. Navy's Bureau of Medicine and Surgery awarded a $98,929.70 firm fixed-price purchase order to Illumina, Inc. for a MiSeq i100 Plus System on September 11, 2025. The contract, which originated from a sole-source Special Notice issued by the Naval Health Research Center in San Diego, covers the procurement of the advanced DNA sequencing instrument along with associated installation and operational qualification services. The award was justified under 10 U.S.C. 3204(a)(1) citing the...
- This is a firm fixed price delivery order awarded by the Northeast Area of the federal agency to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $15,078.24 contract is for a MiSeq silver support plan, which provides maintenance and technical support services for Illumina's MiSeq sequencing system. The award does not have a set-aside designation. Illumina has a history of providing a range of sequencing platforms, consumables, and bioinformatics products to...
- Illumina, Inc. has been awarded a purchase order valued at $89,930.78 for annual MiSeq support and maintenance services, with an ultimate completion date of October 27, 2029. The contract, awarded on August 12, 2024, by the Office of Acquisitions and Grants, utilizes firm fixed pricing with no set-aside designation. Performance will take place in Honolulu, Hawaii. The MiSeq is a mid-throughput genomic sequencing instrument widely used in research and diagnostic applications, and this contract...
- This is a $48,647 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer and provider of genomic sequencing and analysis solutions. The contract is for the purchase of Illumina's genetic sequencing products, including NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, and support services. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that...
- This firm fixed-price purchase order contract was awarded by the Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $98,450.40, is to provide the agency with TruSeq Nano DNA Kits and MiSeq Reagent Kit V2 for genomic sequencing and analysis. This appears to be a delivery order under a larger Indefinite Delivery Contract worth up to $3.3 million that supports the Navy's nucleic acid...